Outlook Therapeutics Newsroom

Buy Rating Justified by Outlook Therapeutics' Advancements and Market Prospects

TipRanksMay 28 20:08 ET

Buy Rating Affirmed for Outlook Therapeutics on Strong EU Prospects and Solid Financial Position

TipRanksMay 17 06:21 ET

Outlook Therapeutics Analyst Ratings

BenzingaMar 27 07:21 ET

Buy Rating for Outlook Therapeutics: Promising FDA Developments and Strong Financial Position Support $50 Price Target

TipRanksMar 27 06:50 ET

Outlook Therapeutics: Buy Rating Affirmed Amid Positive European Developments and Anticipated U.S. Market Success

TipRanksMar 25 08:40 ET

Outlook Therapeutics Analyst Ratings

BenzingaMar 25 08:31 ET

Buy Rating Affirmed for Outlook Therapeutics: European Endorsement and Pivotal US Study Progress Signal Strong Market Potential

TipRanksMar 24 22:50 ET

Buy Rating Affirmed for Outlook Therapeutics Amidst Strong Financial Positioning and Advancing Clinical Trials

TipRanksMar 18 23:50 ET

Buy Rating Affirmed for Outlook Therapeutics Amidst Promising Market Prospects for ONS-5010/Lytenava

TipRanksFeb 16 08:15 ET

Outlook Therapeutics Stock Climbs 13% Amid Chardan Upgrade

Seeking AlphaFeb 15 14:52 ET

Outlook Therapeutics Analyst Ratings

BenzingaFeb 15 07:26 ET

Buy Rating Affirmed for Outlook Therapeutics on Strategic Progress and Strong Financial Positioning

TipRanksFeb 15 06:27 ET

Analysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), Outlook Therapeutics (OTLK) and Leap Therapeutics (LPTX)

TipRanksJan 24 06:41 ET

Ascendiant Capital Maintains Buy on Outlook Therapeutics, Raises Price Target to $2

BenzingaDec 29, 2023 06:47 ET

Outlook Therapeutics Analyst Ratings

BenzingaDec 29, 2023 06:39 ET

Capital One Upgrades Outlook Therapeutics to Overweight, Announces $5 Price Target

BenzingaDec 27, 2023 08:58 ET

Outlook Therapeutics Analyst Ratings

BenzingaDec 27, 2023 08:56 ET

Analysts Conflicted on These Healthcare Names: Outlook Therapeutics (OTLK) and Cytokinetics (CYTK)

TipRanksDec 20, 2023 06:10 ET

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Regeneron (REGN) and Outlook Therapeutics (OTLK)

TipRanksNov 29, 2023 01:30 ET

Analysts Offer Insights on Healthcare Companies: Merus (MRUS) and Outlook Therapeutics (OTLK)

TipRanksNov 28, 2023 06:20 ET